BofAS Reduces ZAI LAB (09688.HK) Price Target to $19.92 Due to Sales Challenges for Core Products
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 10 2025
0mins
Source: aastocks
Financial Performance: ZAI LAB reported a 13% year-over-year increase in total revenue for Q3 2025, reaching US$116 million, with product revenue also growing by 13% to US$115 million.
Brokerage Adjustments: BofA Securities lowered its target prices for ZAI LAB's US stock and H-shares due to sales pressure on core products, maintaining a Neutral rating as R&D pipeline progress met expectations.
Analyst Views on 09688
Wall Street analysts forecast 09688 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 09688 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 15.480
Low
Averages
High
Current: 15.480
Low
Averages
High
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
